Artificial intelligence (AI) software developer Riverain Technologies plans to announce the growth of relationships with other companies in lung imaging at the RSNA 2021 annual meeting.
Riverain will highlight the partnerships complementing its ClearRead suite of applications, which help detect disease using patented vessel CT and bone x-ray suppression technology in thoracic images, including expanded relationships with Aidoc, Imbio, and Volpara Health and enhanced collaborations with PACS vendors like Sectra and Nuance.
